SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-282256
Filing Date
2017-09-12
Accepted
2017-09-12 07:08:06
Documents
15
Period of Report
2017-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d449398d8k.htm 8-K 17905
2 EX-99.1 d449398dex991.htm EX-99.1 12262
3 EX-99.2 d449398dex992.htm EX-99.2 17320
4 GRAPHIC g449398ex99_1s10g1.jpg GRAPHIC 226470
5 GRAPHIC g449398ex99_1s11g1.jpg GRAPHIC 315902
6 GRAPHIC g449398ex99_1s12g1.jpg GRAPHIC 242667
7 GRAPHIC g449398ex99_1s1g1.jpg GRAPHIC 75457
8 GRAPHIC g449398ex99_1s2g1.jpg GRAPHIC 547538
9 GRAPHIC g449398ex99_1s3g1.jpg GRAPHIC 240950
10 GRAPHIC g449398ex99_1s4g1.jpg GRAPHIC 283450
11 GRAPHIC g449398ex99_1s5g1.jpg GRAPHIC 268049
12 GRAPHIC g449398ex99_1s6g1.jpg GRAPHIC 148938
13 GRAPHIC g449398ex99_1s7g1.jpg GRAPHIC 146071
14 GRAPHIC g449398ex99_1s8g1.jpg GRAPHIC 212466
15 GRAPHIC g449398ex99_1s9g1.jpg GRAPHIC 241437
  Complete submission text file 0001193125-17-282256.txt   4112206
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 171080042
SIC: 2834 Pharmaceutical Preparations